Mesothelioma Cancer Resources Blog
-
Preclinical evaluation of MORAb-009, a chimeric antibody targeting tumor-associated mesothelin
Source: CancerImmunity.org People often speak mistakenly of cancer as if it were a single disease that just happens to target different areas of the body. In fact, cancer is not a single disease, but a family of diseases whose propagation is driven by a breakdown of the same cellular processes that are normally responsible for …
Label: Mesothelioma
Posted on Friday, Feb 29, 2008 -
EGFR and PDGFR Differentially Promote Growth In Malignant Epitheloid Mesothelioma Of Short- And Long-term Survivors
Source: Pubmed.gov One of the most difficult aspects of a mesothelioma diagnosis for the patient and his or her family is coming to terms with the disease’s median survival figure, which states that the average life expectancy after diagnosis is only between 8 and 14 months long. Less than 10% of patients will survive for …
Label: Mesothelioma
Posted on Thursday, Feb 28, 2008 -
NCGR Software Enables Identification of Mutated Genes Unique to Mesothelioma Tumors
Source: Fox Business.com The National Center for Genome Resources has announced the launch of Alpheus, the first web-based software system designed for the analysis of massive DNA sequencing projects. The system will enable researchers to analyze extremely large DNA data sets to find individual, patient-specific gene mutations. Doctors from the International Mesothelioma Program at Brigham …
Label: Mesothelioma
Posted on Tuesday, Feb 26, 2008
Mike is a licensed attorney and the former editor of North Carolina Lawyers Weekly and South Carolina Lawyers Weekly. He has contributed numerous articles to the North Carolina State Bar Journal and is a co-author of Capital Lawyers, a history of the Wake County (NC) Bar.
Gregory Froom is a licensed North Carolina attorney and the former editor of North Carolina Lawyers Weekly and South Carolina Lawyers Weekly.